Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry.

Atzeni F;Sarzi Puttini P;Botsios C;Carletto A;CIPRIANI, PAOLA;Favalli EG;Frati E;Foschi V;Gasparini S;Giardina A;Gremese E;Iannone F;Sebastiani M;Ziglioli T;Biasi D;Ferri C;Galeazzi M;Gerli R;GIACOMELLI, Roberto;Gorla R;Govoni M;Lapadula G;Marchesoni A;Salaffi F;Punzi L;Triolo G;Ferraccioli G.

2012-01-01